Therapeutic Solutions International, Inc.
TSOI · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $3 | $15 | $66 | $12 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $4 | $16 | $67 | $13 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -52.1% | 41.7% | 132.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 62.9% | 61.6% | 70.9% | 79.6% |
| EBITDA | -$1 | -$3 | -$2 | -$2 |
| % Margin | -1,502.5% | -1,444% | -1,596.9% | -3,016% |
| Net Income | -$2 | -$4 | -$3 | -$2 |
| % Margin | -2,191.9% | -1,844.6% | -2,029% | -3,509.7% |
| EPS Diluted | -0.001 | -0.002 | -0.001 | -0.001 |
| % Growth | 53.3% | -15.4% | -8.3% | – |
| Operating Cash Flow | -$1 | -$1 | -$1 | -$1 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$1 | -$1 | -$1 |